3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
109
Endometrial Neoplasms
16
Neoplasm Metastasis
10
Polycystic Ovary Syndrome
9
Ovarian Neoplasms
7
Neoplasms
7
Advanced Breast Cancer
5
Triple Negative Breast Neoplasms
4
Prostatic Neoplasms
4
Fallopian Tube Neoplasms
4
Recurrence
3
Infertility
3
Carcinoma, Intraductal, Noninfiltrating
3
Breast Neoplasms, Male
3
Squamous Cell Carcinoma of Head and Neck
2
Progesterone Resistance
2
Neoplasms by Site
2
Hereditary Sensory and Autonomic Neuropathies
2
Head and Neck Neoplasms
2
HR+/HER2- Breast Cancer
2
Estrogen Receptor-positive Breast Cancer
2
Endometrial Hyperplasia
2
Cystadenocarcinoma, Serous
2
Carcinoma, Non-Small-Cell Lung
2
Breast Diseases
2
Breast Cancer Metastatic
2
Breast Cancer Female
2
Uterine Cervical Neoplasms
1
Unilateral Breast Neoplasms
1
Small Cell Lung Carcinoma
1
Interventions
Magnetic Resonance Spectroscopy
5
Specimen Handling
4
Biopsy
3
Steroids
2
Hormones
2
Cyclin-Dependent Kinase Inhibitor p18
2
Cyclin-Dependent Kinase Inhibitor p16
2
trastuzumab deruxtecan
1
trastuzumab biosimilar HLX02
1
taxane
1
radium Ra 223 dichloride
1
pertuzumab
1
naxitamab
1
eicosapentaenoic acid ethyl ester
1
eicosapentaenoic acid ethanolamide
1
binimetinib
1
abemaciclib
1
X-Rays
1
Trastuzumab
1
Taxoids
1
Taxes
1
Radiotherapy
1
Radiosurgery
1
Radiation
1
Photons
1
Paclitaxel
1
PF-05280014
1
Ontruzant
1
Ogivri
1
Mastectomy, Simple
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Anatomic Stage IV Breast Cancer AJCC v8
×
Letrozole
×
1 year
×
Clear all
No trials found.